1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Fusilev: new trials by email Literature Review of Fusilev trials Research Report on Fusilev
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC Irinotecan, Oxaliplatin, Levoleucovorin - Metastatic Colorectal Cancer | Phase 2 | Withdrawn | Fujian Cancer Hospital | 2017-07-20 | 2018-03-27 |
China (1)
Rongbo Lin, MD (1)